Brandywine Global Investment Management, LLC Royalty Pharma PLC Transaction History
Brandywine Global Investment Management, LLC
- $13.7 Billion
- Q2 2025
A detailed history of Brandywine Global Investment Management, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 1,260,205 shares of RPRX stock, worth $49.1 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
1,260,205
Previous 1,720,376
26.75%
Holding current value
$49.1 Million
Previous $53.6 Million
15.22%
% of portfolio
0.33%
Previous 0.4%
Shares
5 transactions
Others Institutions Holding RPRX
# of Institutions
514Shares Held
282MCall Options Held
1.99MPut Options Held
384K-
Morgan Stanley New York, NY46.6MShares$1.82 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY23MShares$897 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA21.9MShares$852 Million0.14% of portfolio
-
Baillie Gifford & CO17.4MShares$677 Million0.48% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$475 Million0.45% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $17B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...